Ocumension Therapeutics (HK:1477) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Ocumension Therapeutics has announced a board meeting scheduled for August 12, 2024, where they will review and approve the interim results for the first half of the year, and discuss the potential issuance of an interim dividend. The meeting will be a significant event for stakeholders as it could influence the company’s stock performance based on the financial outcomes and dividend decisions.
For further insights into HK:1477 stock, check out TipRanks’ Stock Analysis page.